Nanobiotix S.A. (EPA:NANO)
France · Delayed Price · Currency is EUR 18.28
-0.38 (-2.04%)
At close: Dec 5, 2025
Nanobiotix Employees
Nanobiotix had 108 employees as of December 31, 2024. The number of employees increased by 6 or 5.88% compared to the previous year.
Employees
108
Change (1Y)
6
Growth (1Y)
5.88%
Revenue / Employee
€98,631
Profits / Employee
€501,388
Market Cap
881.38M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 108 | 6 | 5.88% |
| Dec 31, 2023 | 102 | 0 | - |
| Dec 31, 2022 | 102 | 2 | 2.00% |
| Dec 31, 2021 | 100 | 10 | 11.11% |
| Dec 31, 2020 | 90 | -20 | -18.18% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| EssilorLuxottica Société anonyme | 153,498 |
| emeis Société anonyme | 83,494 |
| Sanofi | 82,878 |
| Eurofins Scientific SE | 62,696 |
| Clariane SE | 61,798 |
| Ramsay Générale de Santé | 40,494 |
| bioMérieux | 14,754 |
| Sartorius Stedim Biotech | 9,901 |
Nanobiotix News
- 12 days ago - Nanobiotix Provides Third Quarter 2025 Operational and Financial Update Along With 2026 Clinical Outlook - GlobeNewsWire
- 12 days ago - Biotech Stock Nanobiotix (NBTX) Is Up 660% This Year -- Here's Why the Rally Could Continue - The Motley Fool
- 23 days ago - NANOBIOTIX Announces Curadigm Nanoprimer Platform Advancements With Updated Plans for Internal Pipeline Development and External Collaborations - GlobeNewsWire
- 4 weeks ago - NANOBIOTIX to Participate in Investor Conferences the Week of November 10th - GlobeNewsWire
- 5 weeks ago - Nanobiotix (NBTX) Secures $71M Financing Deal with HealthCare Royalty - GuruFocus
- 5 weeks ago - NANOBIOTIX Announces Strategic Royalty Monetization Agreement With Healthcare Royalty for up to $71 Million and Extends Cash Runway Toward Long-Term Growth - GlobeNewsWire
- 2 months ago - Nanobiotix (NBTX) Sees Stock Rise on Promising Cancer Drug Trial Results - GuruFocus
- 2 months ago - Nanobiotix gains after early-stage trial data for J&J-partnered cancer drug - Seeking Alpha